Skip to main
LEXX

LEXX Earnings Dates & Reports

LEXX Most Recent Earnings

Report Date
Period EndingQ3 2026
Est. EPS-$0.06
Actual EPS-$0.08
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

LEXX Earnings per Share (EPS) History

Signup for full access
Browse free

LEXX Latest Earnings

The value each LEXX share was expected to gain vs. the value each share gained.

LEXX reported its most recent earnings on for Q3 2026, posting earnings per share (EPS) of -$0.08. This exceeded analysts' expectations of -$0.06 by 33.33%, marking a Miss.

For comparison, Lexaria Bioscience Corp reported EPS of -$0.21 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.90.

LEXX Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2026
-$0.90
Q3 2026
-$0.06-$0.08+33.33%
Q2 2026
-$0.08-$0.06-25.00%
Q1 2026
-$0.08-$0.07-12.50%
Q4 2025
-$0.16-$0.13-18.75%
View all

LEXX Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Lexaria Bioscience Corp’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

LEXX Earnings FAQs

LEXX last reported earnings on Jul 13, 2026 for Q3 2026, posting an EPS of -$0.08, which Miss the estimate of -$0.06 by 33.33%.

For Q3 2026, LEXX reported an EPS of -$0.08, missing analysts' estimate of -$0.06 by 33.33%.

For Q3 2026, LEXX Miss expectations with an actual EPS of -$0.08 vs. an estimated EPS of -$0.06.

Following the last earnings report on Jul 13, 2026, LEXX's stock price moved — from — to —.

The next LEXX earnings call is scheduled for Nov. 27, 2026, where executives will discuss financial results and outlook.

Lexaria Bioscience Corp (LEXX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.